4-chloro-N-(2,6-dimethyl-1-piperidyl)-3-sulfamoyl-benzamide
ADVERTISEMENT
- Molecular formula
- C14H18ClN3O3S
- CAS Number
- 32997-05-0
- IUPAC Name
- 4-chloro-N-(2,6-dimethyl-1-piperidyl)-3-sulfamoyl-benzamide
- Molecular Weight
- 342.83g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3100g/cm3
- Synonyms
- Chlosudimeprimylum
Identification
Interesting facts
Interesting Facts about 4-Chloro-N-(2,6-dimethyl-1-piperidyl)-3-sulfamoyl-benzamide
This compound is an intriguing member of the sulfamide class, known for its *pharmacological properties*. The structural complexity is notable, featuring a benzamide moiety linked to a piperidine ring, making it an interesting subject for medicinal chemistry research. Here are some fascinating points about this compound:
- Biological Activity: Sulfamoylbenzamides are often studied for their potential *antimicrobial and anti-inflammatory activities*. This highlights the significance of the compound in drug development.
- Mechanism of Action: This compound, like other sulfamides, may act by inhibiting *carbonic anhydrase*, an enzyme critical in many physiological processes. A deeper understanding could pave the way for new therapies.
- Versatility in Synthesis: The synthetic pathway for creating such compounds can vary widely, allowing for modifications that can enhance potency or selectivity, making it a fantastic model for students learning about organic synthesis.
- Chirality: The presence of a chiral center in the piperidine ring suggests that enantiomers could display different biological effects, an essential consideration in drug design.
- Environmental Impact: The stability and persistence of this compound in biological and environmental systems are critical factors to consider in assessments of its safety and ecological toxicity.
As you explore the chemistry behind 4-chloro-N-(2,6-dimethyl-1-piperidyl)-3-sulfamoyl-benzamide, remember the interconnectedness of its structure and function, which emphasizes the *vital role* of chemical compounds in developing therapeutic agents.